Navigation Links
Elegant delivery
Date:7/15/2012

be able to accomplish the dual treatment with proper targeting and a sustained release that proved safer for the animals undergoing therapy.

Critical to the treatment's success is the ability to package two completely different kinds of molecules--large, water-soluble proteins like IL-2 and tiny, water-phobic molecules like the TGF-β inhibitor-into a single package.

While many NLGs are injected into a patient during treatment, each one is a sophisticated system composed of simple-to-manufacture, yet highly functional, parts. The outer shell of each NLG is made from an FDA-approved, biodegradable, synthetic lipid that the researchers selected because it is safe, degrades in a controlled manner, is sturdy enough to encapsulate a drug-scaffolding complex, and is easy to form into a spherical shell.

Each shell surrounds a matrix made from biocompatible, biodegradable polymers that the engineers had already impregnated with the tiny TGF-β inhibitor molecules. The researchers then soaked those near-complete spheres in a solution containing IL-2, which gets entrapped within the scaffolding, a process called remote loading.

The end result is a nanoscale drug delivery vehicle that appears to fit the narrow parameters necessary for successful treatment. Each NLG is small enough to travel through the bloodstream, yet large enough to get entrapped in leaky cancer blood vessels.

The NLG lipid shells have the strength to carry drugs into the body, yet are degradable so that they can deliver their cargo. And most critically, the spherules are engineered to accommodate a wide range of drug shapes and sizes. Ultimately, such a system could prove powerful not only for melanoma, but for a range of cancers.


'/>"/>
Contact: Josh Chamot
jchamot@nsf.gov
703-292-7730
National Science Foundation
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. Ben-Gurion U. licenses drug delivery platform for central nervous system diseases to NY biotech firm
2. Delivery of gene-therapy for heart disease boosted 100-fold; now in 100-patient trial
3. Light-induced delivery of nitric oxide eradicates drug-resistant bacteria
4. Oligonucleotide Delivery: Biology, Engineering and Development Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Elegant delivery
(Date:8/18/2014)... satellite image of Antarctica, and the imagery will help ... the effects of climate change. , Thanks to a ... and Associates Ltd. (MDA), the prime contractor for the ... at UWaterloo, the mosaic is free and fully accessible ... Using Synthetic Aperture Radar with multiple polarization modes aboard ...
(Date:8/18/2014)... Researchers at UT Southwestern Medical Center have found a ... type of molecule known as long non-coding RNA. , The ... of many bodily functions, from waking and sleeping to body ... cycle that is influenced by external cues such as light ... are abundant in many organisms, what they do in the ...
(Date:8/18/2014)... small body size associated with the pygmy phenotype ... according to an international team of researchers, but ... same genetic underpinning, suggesting a more recent adaptation ... hunter-gatherers have adapted to their very challenging environments," ... and biology, Penn State. "Tropical rainforests are difficult ...
Breaking Biology News(10 mins):Waterloo makes public most complete Antarctic map for climate research 2Researchers obtain key insights into how the internal body clock is tuned 2Researchers obtain key insights into how the internal body clock is tuned 3Pygmy phenotype developed many times, adaptive to rainforest 2
... Molecular Biology in July named 12 scientists the winners ... one winner from 2011 will give talks at the ... Stuart Kornfeld, a professor at Washington University in St. ... Chemistry Lectureship. The award recognizes outstanding lifetime scientific ...
... Laboratory,s European Bioinformatics Institute (EMBL-EBI) has been awarded the ... PubMed Central (UKPMC), the free online literature resource for ... has grown from a simple mirror of the National ... a stand-alone site providing access to a repository of ...
... tree trunk, at first sight a colugo might be mistaken ... into a graceful glide, spreading wide the enormous membrane that ... to 150m. So, when Greg Byrnes and his colleague Andrew ... around for a mammal to carry the accelerometer/radio transmitter backpacks ...
Cached Biology News:12 scientists named ASBMB award winners 212 scientists named ASBMB award winners 312 scientists named ASBMB award winners 4European Bioinformatics Institute to lead UK PubMed Central in 2011-2016 2Colugos glide to save time, not energy 2
(Date:8/19/2014)... Robin Williams’ passing is a sad ... an individual. Symptoms range from slowness of voluntary ... and severe depression. Parkinson’s disease progressively gets worse ... producing neurons of the brain. As these patients ... and progressively gets worse, they look for options. ...
(Date:8/19/2014)... 2014 CSSi, the leader in patient recruitment ... formation of the company,s Medical and Clinical Advisory Board ... Dr. William E. Gannon, Jr. to the ... The MCAB, with Dr. Gannon,s leadership, will ... and set strategic goals for the advancement and development ...
(Date:8/19/2014)... - iCo Therapeutics Inc. ("iCo" or "the Company") (TSX-V: ... Oral Amphotericin B (Oral Amp B) drug candidate ... ImmuneCarta®, the immune monitoring business unit of Caprion, ... Amp B in reactivating latent HIV viral reservoirs ... with antiretroviral therapy. Memory cells, ...
(Date:8/18/2014)... new therapy developed by researchers at the University ... and Columbia University Medical Center (CUMC) may help ... treatment. , The researchers demonstrated in a ... selectively inhibit blood vessel re-narrowing and simultaneously promote ... balloon catheter to open narrowed or blocked arteries. ...
Breaking Biology Technology:As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 2As We Mourn Robin Williams’ Passing, His Death Sheds Light on Patients Struggling with Parkinson’s Disease 3CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 2CSSi Appoints Dr. William E. Gannon, Jr. to Newly Formed Medical and Clinical Advisory Board 3iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 2iCo Therapeutics Announces Positive Oral Amphotericin B Study Results 3Selective therapy may improve artery repair after interventional cardiovascular procedures 2Selective therapy may improve artery repair after interventional cardiovascular procedures 3
... Md., April 24 United,Therapeutics Corporation (Nasdaq: ... 2008 first quarter financial results before the open ... Therapeutics will host a half-hour teleconference on Thursday,May ... teleconference is accessible by,dialing 1-800-603-1777, with international callers ...
... an improved governance structure, the benefits of nanotechnology may ... not trust the cutting-edge technology, says David Rejeski, director ... on Thursday, April 24, before the Senate subcommittee on ... dark horse in nanotechnologys future, states Rejeski in his ...
... (Nasdaq: IMRX ) today announced that it ... to which it has satisfied its obligations,under its ... in,connection with its acquisition of urokinase. As a ... remaining inventory of finished,product, all regulatory and clinical ...
Cached Biology Technology:Improved governance needed to realize nanotech's benefits 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 2ImaRx Therapeutics Satisfies Abbott Note Obligation Associated With the Acquisition of Urokinase 3